Recruiting

Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research

NCT04906928 · Fondation Ophtalmologique Adolphe de Rothschild

Recruiting

In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title

Evaluation of the Performance of a 3D FGAPSIR Sequence by MRI in the Detection and Characterization of Spinal Cord Injuries in Patients With Multiple Sclerosis

About this study

* verification of inclusion and non-inclusion criteria * information and collection of consent * standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), 3D STIR and 3D PSIR sequence. * 3D FGAPSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 40 minutes (instead of 30 minutes)

Eligibility criteria

Inclusion Criteria: * Patient over 18 years old * To benefit from a medullary exploration planned by 3T MRI as part of a first evaluation or a reassessment of inflammatory involvement of the nevrax * Express consent to participate in the study * Affiliate or beneficiary of a social security scheme Exclusion Criteria: * Patient benefiting from a legal protection measure * Pregnant, parturient or breastfeeding woman * Absolute or relative contraindication to MRI

Study design

Enrollment target: 200 participants

Age groups: adult, older_adult

Timeline

Starts: 2023-10-25

Estimated completion: 2026-10

Last updated: 2026-01-05

Interventions

Device: MRI

Primary outcomes

• estimate the number of lesions detected with the 3D FGAPSIR sequence and not detected with the 3D PSIR sequence. (1 DAY)

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild · network

Contacts & investigators

Contactamélie YAVCHITZ · contact · ayavchitz@for.paris · 0148036454

All locations (1)

Fondation Ophtalmologique Adolphe de Rothschild (FOR)Recruiting

Paris, France

View on ClinicalTrials.gov ↗Find similar trials